Links Progenetics & GTC ProGenetics received $0.5 million and will get an additional amount of approximately $0.5 million in the second quarter of 2008. GTC will also receive a small equity interest in the company... ProGenetics also obtained a nonexclusive license to GTC’s patent in the U.S. for the transgenic expression of therapeutic proteins in milk. This will enable the company to develop these products outside North America, Europe, and Japan.
GTC previously obtained from ProGenetics an exclusive license to a number of recombinant plasma proteins including human coagulation factor IX, for North America, Europe, and Japan. ProGenetics received $500,000 upon signing of that agreement. LFB will fund the final $500,000 license fee payment due to ProGenetics in the second quarter of 2008. http://www.genengnews.com/news/bnitem.as...
During Q4 2008, two monoclonal antibodies developed by LFB's R&D division (an anti-D monoclonal and a batch of anti-CD 20) both achieved a significant development milestone - first-in-man administration.
"I think the advantages of GTCB's technology and pipeline will be seen by some BP with deep pockets as too damned easy a way to make lots of money in 4-5 years, not to simply snap it up before the French have closed their trap."
Hello....what are they waiting for? Cox & company have been "shopping" for partners for years. Don't you think they've talked to everyone yet?
For most large Pharms GTCB could be purchased for "peanuts".
Market Data 
Markets 
AI
